Tag:
Bazedoxifene
Latest Headlines
Latest Headlines
Wyeth gets approvable letter for bazedoxifene
The FDA handed Wyeth a third approvable letter for bazedoxifene, a treatment for postmenopausal osteoporosis. In the letter, the FDA said it needed more information concerning the incidence of stroke
Wyeth's reports strong Phase III bazedoxifene data
At the American Society for Bone and Mineral Research Annual Meeting, Wyeth presented strong Phase III data for its osteoporosis drug. Bazedoxifene 20 mg and 40 mg significantly reduced the risk of
